Category: FEM news

King’s College London and RCT Establish New Anticancer Drug Discovery Company

A new company, Femtogenix Ltd, has been formed by King’s College London and Research Corporation Technologies (RCT) of Tucson, Arizona (USA), with RCT also providing Series A funding for the venture. The new company is based on the work of David Thurston, Professor of Drug Discovery, and his colleagues Dr Miraz Rahman and Dr Paul… Read more »